Skip to main content
OpenTrials
Completed

NCT Number: NCT01048710

Treatment of Medial Compartmental Osteoarthritis Grade 1-4 With TomoFix™ Small or Conservatively

The primary objective of this prospective multicenter study is to assess whether the functional outcome measured with the Knee Injury and Osteoarthritis Outcome Score (KOOS) for patients with medial unicompartmental osteoarthritis and osteonecrosis of the knee treated with open wedge high tibial osteotomy (HTO) using the TomoFix™ Small is better than the functional outcome after conservative treatment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Toyama Municipal Hospital

Toyama, 939-8511, Japan

About this study

Osteoarthritis (OA) of the knee (gonarthrosis) is a common medical condition and causes pain and disability. By 65 years of age, the majority of the US population has radiographic evidence of OA and 11% have symptomatic OA of the knee. In Japan, OA of the knee is more common due to the common sitting style with maximally flexed knees and parallel position of both legs.

High Tibial Osteotomy (HTO) for knee OA is a standard procedure in orthopedic surgery. Six years ago, HTO using TomoFix™ was introduced. Because Asian people have different geometric dimensions of the tibiae, an adaptation of size and shape was necessary, and the new TomoFix™ Small was developed. Although there is widespread literature concerning osteotomy for treating knee OA, literature assessing patient outcome after open wedge HTO using TomoFix™ is rare and for TomoFix™ Small, this data is still nonexistent. Therefore, the primary aim of the present multicenter study is to evaluate patient functional outcome using the KOOS. Since a proportion of patients with the indication for HTO refuse surgery and opt to receive conservative treatment, the functional results of patients treated with HTO using TomoFix™ Small will be compared with these patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 40 years of age and older
  • Patients with OA Grade 1-4 (Kellgren-Lawrence) or osteonecrosis (ON) Stage 2-4 (according to the Koshino classification)
  • Indication for open wedge HTO with the TomoFix™ Small
  • No ligamental laxity
  • Signed written informed consent (by the subjects or legal guardian) and agreement to attend all planned follow-ups
  • Willing and able to comply with the postoperative management program
  • Able to understand and read country national language at an elementary level

Exclusion criteria

  • Femoro-tibial angle (FTA) > 185o (standing view x-ray)
  • Flexion contracture > 15o
  • Total knee replacement or unicompartmental knee on the contralateral side
  • Infections located between the middle of the femur and the ankle
  • Systemic bacterial infections
  • Severe osteoarthritis or surgery of the hip joint
  • Smoking of more than 20 cigarettes per day
  • Immunodeficiency or compromised host
  • Patients who have participated in any other device or drug related clinical trial within the previous month
  • ACL/PCL reconstruction of the same knee
  • Severe osteoarthritis of the ipsilateral ankle joint

For conservative group only:

  • HTO on the contralateral side
  • Major surgery on both knees (minor surgery as arthroscopic meniscectomy and synovectomy is allowed)

Treatment and study plan

No intervention

Other

Primary outcomes

  1. Knee Injury and Osteoarthritis Outcome Score (KOOS)

    Time frame: 1 month, 3 months, 6 months, 12 months, 24 months, 3 years, 4 years, and 5 years

Secondary outcomes

  1. Patient-evaluated function of the knee and quality of life, a. assessed with the Oxford-12-item knee score b. assessed with the WOMAC (as calculated from the KOOS)

    Time frame: 1 month, 3 months, 6 months, 12 months, 24 months, 3 years, 4 years, and 5 years

  2. Clinician-evaluated function of the knee, assessed with the Japanese Orthopaedic Association (JOA) score

    Time frame: 1 month, 3 months, 6 months, 12 months, 24 months, 3 years, 4 years, and 5 years

  3. Health-related quality of life assessed by the generic Short Form-36 (SF-36) instrument

    Time frame: 1 month, 3 months, 6 months, 12 months, 24 months, 3 years, 4 years, and 5 years

  4. Range of motion (ROM)

    Time frame: 1 month, 3 months, 6 months, 12 months, 24 months, 3 years, 4 years, and 5 years

  5. Local and general pain, assessed with the Visual Analogue Scale (VAS)

    Time frame: 1 month, 3 months, 6 months, 12 months, 24 months, 3 years, 4 years, and 5 years

  6. Possibility and duration of the Japanese sitting style

    Time frame: 3 months, 6 months, 12 months, 24 months, 3 years, 4 years, and 5 years

  7. Surgery details, Postoperative treatment, Postoperative rehabilitation, Utilization

    Time frame: postoperative period

  8. Evaluation of degenerated and regenerated cartilage (arthroscopic findings assessed according to ICRS and Outerbridge / Koshino)

    Time frame: intraoperative and after 2 years

  9. Radiological parameters (e.g. union, delayed union, Kellgren-Lawrence classification, joint space narrowing, tibial slope, tibia vara, patella height according to Blackburne-Peel, modified Insall-Salvati ratio, subluxation of patella)

    Time frame: 1 month, 3 months, 6 months, 12 months, 24 months, 3 years, 4 years, and 5 years

  10. Complications and mortality

    Time frame: 1 month, 3 months, 6 months, 12 months, 24 months, 3 years, 4 years, and 5 years

Sponsors and collaborators

Lead sponsor

Synthes GmbH

Industry

Collaborators

  • Johnson & Johnson K.K. Medical Company

Registry information

Official study title

Treatment of Medial Compartmental Osteoarthritis Grade 1-4 (Kellgren-Lawrence) or Osteonecrosis With TomoFix™ Small or Conservatively

Important dates

Study start
2009
Primary completion
2015
Study completion
2018
First posted
Jan 14, 2010
Registry last updated
Aug 22, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.